Improving access to ABC medicines in high-income countries: the perspective and role of patient advocates, clinicians and pharma
Wednesday June 23, 2026
15:00 [GMT]
Why does it take so long for approved new medicines to get to the patients who need them? For too many advanced breast cancer (ABC) patients, the hope offered by new drugs remains out of reach, even in high-income countries.
What can we all do to ensure faster and fairer access to ABC medicines? Our panel of experts will share the tools and tips that they have seen make a difference. Expect to take away some practical messages and angles that will help you make progress in your own country.
Topics and SpeakersWho may this interest?
- Unequal rights for ABC medicines in high-income countries
Dr Fatima Cardoso, medical oncologist and president of ABC Global Alliance - Why are we waiting – and what can we do about it? Trends, barriers and clever moves in market access
Christel Jansen, The Access Embassy - Clearing the hurdles – tools from pharma that can help improve access in Europe
Mihai Rotaru, Director Market Access, EFPIA - How to be heard – how advocates have worked successfully in-country
Kirstin Spencer, patient advocate - Better for all – how can clinicians help improve access?
Dr Fatima Cardoso
- Oncologists
- Patient advocates
- Cancer patients
In association with:
